BARRIERS TO PRESCRIBING MEDICATIONS TO PATIENTS WITH MULTIPLE SCLEROSIS: A COMPARISON OF HEALTH CARE PROVIDER PERCEPTIONS IN EUROPEAN UNION (EU) AND THE UNITED STATES

被引：0
|
作者：
Narayanan, S. [1 ]
Khan, H. [2 ]
Gabriele, S. [2 ]
White, J. [2 ]
机构：
[1] Ipsos Healthcare, Columbia, MD USA
[2] Ipsos Healthcare, London, England
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 03期
关键词：
D O I：
10.1016/j.jval.2014.03.388
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND57
引用
收藏
页码：A66 / A66
页数：1
相关论文
共 50 条
  • [31] Postmarket Safety Communication for Protection of Public Health: A Comparison of Regulatory Policy in Australia, Canada, the European Union, and the United States
    Bhasale, Alice L.
    Sarpatwari, Ameet
    De Bruin, Marie L.
    Lexchin, Joel
    Lopert, Ruth
    Bahri, Priya
    Mintzes, Barbara J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 (06) : 1424 - 1442
  • [32] The impact of medical insurance on health care access and quality for people with multiple sclerosis in the United States: A scoping review
    Moghavem, Nuriel
    Castaneda, Gloria del Rosario
    Chatfield, Amy J.
    Amezcua, Lilyana
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 299 - 307
  • [33] All-Cause Health Care Utilization and Costs Associated with Newly Diagnosed Multiple Sclerosis in the United States
    Asche, Carl V.
    Singer, Mendel E.
    Jhaveri, Mehul
    Chung, Hsingwen
    Miller, Aaron
    [J]. JOURNAL OF MANAGED CARE PHARMACY, 2010, 16 (09): : 703 - 712
  • [34] Improvement in Health-Related Quality of Life in Multiple Sclerosis Patients Receiving Natalizumab in the United States
    Hou, Likun
    Stephenson, Judith J.
    Rajagopalan, Krithika
    Agarwal, Sonalee S.
    Kamat, Siddhesh A.
    [J]. NEUROLOGY, 2010, 74 (09) : A161 - A161
  • [35] IMPROVEMENT IN HEALTH-RELATED QUALITY OF LIFE IN MULTIPLE SCLEROSIS PATIENTS RECEIVING NATALIZUMAB IN THE UNITED STATES
    Hou, L.
    Stephenson, J. J.
    Agarwal, S. S.
    Rajagopalan, K.
    Kamat, S. A.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A143 - A143
  • [36] ANALYSIS OF HEALTH CARE RESOURCE USE AND COST IN DMT TREATED VERSUS NON-DMT TREATED PATIENTS WITH MULTIPLE SCLEROSIS IN THE UNITED STATES
    Livingston, T.
    Fay, M.
    Iyer, R.
    Eisenberg, S.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A62 - A62
  • [37] Access, barriers, and unmet needs to multiple sclerosis care among different health coverage: A cohort of Argentinean Patients
    Carnero Contentti, Edgar
    Pablo Pettinicchi, Juan
    Lopez, Pablo
    Alonso, Ricardo
    Garcea, Orlando
    Balbuena Aguirre, Maria Eugenia
    Pablo Hryb, Javier
    Luis Di Pace, Jose
    Perassolo, Monica
    Celeste Curbelo, Maria
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (01) : 174 - 174
  • [38] HEALTH CARE RESOURCE UTILIZATION AND COSTS IN CHRONIC BRONCHITIS PATIENTS TREATED WITH COPD MEDICATIONS FROM A MANAGED CARE POPULATION IN THE UNITED STATES
    Abudagga, A.
    Sun, S. X.
    Tan, H.
    Kavati, A.
    Solem, C. T.
    Botteman, M. F.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A56 - A57
  • [39] COMPARISON OF DISEASE STATUS, TREATMENTS AND OUTCOMES OF PATIENTS WITH PSORIATIC ARTHRITIS RECEIVING THEIR FIRST BIOLOGIC IN THE EUROPEAN UNION AND UNITED STATES
    Narayanan, S.
    Baskett, A.
    Lu, Y.
    Hutchings, R.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A571 - A571
  • [40] A COMPARISON OF THE ECONOMIC BURDEN AND HEALTH CARE UTILIZATIONS OF VETERAN PATIENTS DIAGNOSED WITH HYPERTENSION IN THE UNITED STATES
    Wang, L.
    Xie, L.
    Du, J.
    Li, L.
    Baser, O.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A522 - A522
12345